Imatinib

AccuChIP Chromatin Immunoprecipitation Internal Controls are designed to improve the accuracy of ChIP experiments. This simple to spike-in reagent is composed of a target-specific peptide sequence covalently bound to a uniquely designed double

A cell-permeable, orally bioavailable 2-phenylaminopyrimidine derived compound that competitively binds to ATP-binding site of Abl and stabilizes the inactive conformation, and acts as a highly potent and reversible inhibitor of Abl (IC 50 = 38, 25

Bestatin is a dipeptide antitumor antibiotic. It shows no inhibition against aminopeptidase A, trypsin, chymotrypsin, elastase, papain, pepsin or themolysin.

Bestatin is a dipeptide antitumor antibiotic. It shows no inhibition against aminopeptidase A, trypsin, chymotrypsin, elastase, papain, pepsin or themolysin.

Bestatin is a dipeptide antitumor antibiotic. It shows no inhibition against aminopeptidase A, trypsin, chymotrypsin, elastase, papain, pepsin or themolysin.

Imatinib is a benzamide derivative used as a is specific tyrosine kinase receptor inhibitor. It is designed to inhibit the breakpoint cluster region (BCR)-Abelson (ABL) fusion protein, which is caused by the Philadelphia chromosome abnormalities.

A cell-permeable, non-toxic, n-octyl ester form of 5-carboxy-8-hydroxyquinoline (IOX1, Cat. No.

Cell Line Origin Human malignant melanoma Cell Line Description Malignant Melanoma. Cell Bank Australia reference number: CBA1349.

MF: C50H83NO21 MF: 1034.21 CAS: 17406-45-0 Purity: 0.9